MESSAGE
| DATE | 2005-04-29 |
| FROM | dspira@att.net (Dave_att)
|
| SUBJECT | Re: [NYLXS - HANGOUT] Rx Ripoff
|
From owner-hangout-at-mrbrklyn.com Fri Apr 29 17:38:59 2005
Received: from www2.mrbrklyn.com (localhost [127.0.0.1])
by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id j3TLcvcX018286
for ; Fri, 29 Apr 2005 17:38:59 -0400
Received: (from majordomo-at-localhost)
by www2.mrbrklyn.com (8.13.1/8.13.1/Submit) id j3TLcvAw018285
for hangout-outgoings; Fri, 29 Apr 2005 17:38:57 -0400
X-Authentication-Warning: www2.mrbrklyn.com: majordomo set sender to owner-hangout-at-nylxs.com using -f
Received: from mtiwmhc12.worldnet.att.net (mtiwmhc12.worldnet.att.net [204.127.131.116])
by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id j3TLcs98018282
for ; Fri, 29 Apr 2005 17:38:56 -0400
Received: from 204.127.135.29 ([204.127.135.29])
by worldnet.att.net (mtiwmhc12) with SMTP
id <2005042917401311200llukve>; Fri, 29 Apr 2005 17:40:17 +0000
Received: from [12.75.139.35] by 204.127.135.29;
Fri, 29 Apr 2005 17:40:11 +0000
From: dspira-at-att.net (Dave_att)
To: Ron Guerin ,
"Michael L. Richardson"
Cc: NYLXS
Subject: Re: [NYLXS - HANGOUT] Rx Ripoff
Date: Fri, 29 Apr 2005 17:40:11 +0000
Message-Id: <042920051740.15450.4272717A000AE2F400003C5A21603759640E9D079F9C0B-at-att.net>
X-Mailer: AT&T Message Center Version 1 (Feb 14 2005)
X-Authenticated-Sender: ZHNwaXJhQGF0dC5uZXQ=
Sender: owner-hangout-at-mrbrklyn.com
Precedence: bulk
X-Keywords:
X-UID: 40422
Status: RO
Content-Length: 1083
Lines: 27
DITTO!
this is obviously a smear campaign against the pharmaceutical industrty. A pharmacist knows his business depends on his customers. would they chance ruining their business by overcharging on a non generic medication? It makes no sense.
-------------- Original message ----------------------
From: Ron Guerin
> Michael L. Richardson wrote:
>
> > I don't know how true this is.
>
> I wouldn't put too much stock in it, for if it comes from a budget
> analyst for the Dept. of Commerce, then she knows she's prepared a
> deliberately misleading report that opens with a scandalous chart about
> non-generic drugs and then goes on to complain about the cost of the
> generics.
>
> The cost of the non-generics, which is what she's trying to enrage
> people with has little to nothing to do with the cost of the active
> ingredient itself, and everything to do with the cost of discovering/
> creating the drug, testing it, and accounting for potential liability.
>
> I have little doubt we're being ripped off, but this piece is garbage.
>
> - Ron
>
|
|
